Anti-GAPDH (HRP conjugated) antibody
Specifications
| Product Cat#: | AB-06-1852 |
| Product type: | Primary antibody |
| Antigen: | GAPDH (HRP conjugated) |
| Immunogen: | Recombinant protein |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:500-1:1000) |
| Reactivity: | Human, Mouse, Rat, Monkey, Chicken, Fish |
| Clonality (clone number): | Monoclonal, JF81-04 |
| Form: | Liquid |
| Buffer: | 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| Alternative names: | 38 kDa BFA-dependent ADP-ribosylation substrate antibody |
| aging associated gene 9 protein antibody | |
| Aging-associated gene 9 protein antibody | |
| BARS-38 antibody | |
| cb609 antibody | |
| EC 1.2.1.12 antibody | |
| Epididymis secretory sperm binding protein Li 162eP antibody | |
| G3P_HUMAN antibody | |
| G3PD antibody | |
| G3PDH antibody | |
| GAPD antibody | |
| GAPDH antibody | |
| Glyceraldehyde 3 phosphate dehydrogenase antibody | |
| Glyceraldehyde-3-phosphate dehydrogenase antibody | |
| HEL-S-162eP antibody | |
| KNC-NDS6 antibody | |
| MGC102544 antibody | |
| MGC102546 antibody | |
| MGC103190 antibody | |
| MGC103191 antibody | |
| MGC105239 antibody | |
| MGC127711 antibody | |
| MGC88685 antibody | |
| OCAS, p38 component antibody | |
| OCT1 coactivator in S phase, 38-KD component antibody | |
| peptidyl cysteine S nitrosylase GAPDH antibody | |
| Peptidyl-cysteine S-nitrosylase GAPDH antibody | |
| wu:fb33a10 antibody |
Show More
Target information
Cell surface proteoglycan that bears heparan sulfate. Binds, via the heparan sulfate side chains, alpha-4 (V) collagen and participates in Schwann cell myelination (By similarity). May act as a catalyst in increasing the rate of conversion of prion protein PRPN(C) to PRNP(Sc) via associating (via the heparan sulfate side chains) with both forms of PRPN, targeting them to lipid rafts and facilitating their interaction. Required for proper skeletal muscle differentiation by sequestering FGF2 in lipid rafts preventing its binding to receptors (FGFRs) and inhibiting the FGF-mediated signaling.
Provider
Erpantech Laboratory
